Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

Autor: Danne, Thomas *, Biester, Torben, Kapitzke, Kerstin, Jacobsen, Sanja H., Jacobsen, Lisbeth V., Petri, Kristin C. Carlsson, Hale, Paula M., Kordonouri, Olga
Zdroj: In The Journal of Pediatrics February 2017 181:146-153
Databáze: ScienceDirect